Public Health authorities highlighted today the positive development of the first week of clinical trials of the Soberana 02 vaccine candidate in Havana.
The National Center for the Production of Laboratory Animals ( CENPALAB by its Spanish acronym) is essential for the development of Cuba's biotechnological industry and has been crucial for the preclinical testing of the island's vaccine candidates against COVID-19.